Effect of 0.9% Saline or Plasma-Lyte 148 as Crystalloid Fluid Therapy in the Intensive Care Unit on Blood Product Use and Postoperative Bleeding After Cardiac Surgery
Sumeet K Reddy, Michael J Bailey, Richard W Beasley, Rinaldo Bellomo, Diane M Mackle, Alex J Psirides, Paul J Young
Journal of Cardiothoracic and Vascular Anesthesia | W B SAUNDERS CO-ELSEVIER INC | Published : 2017
Rinaldo Bellomo and Paul Young report receiving honoraria from Baxter Healthcare Pty Ltd for consulting activities. Sumeet Reddy has received a Clinical Research Training Fellowship from the Health Research Council of New Zealand. The Medical Research Institute of New Zealand is supported by Health Research Council of New Zealand Independent Research Organization Funding. The Medical Research Institute of New Zealand and Australian and New Zealand Intensive Care Research Centre have received research grants from Baxter Healthcare Pty Ltd. In addition, the study fluid was supplied and distributed by Baxter Healthcare Pty Ltd. Baxter Healthcare Pty Ltd was not involved in the study design, conduct, data collection, statistical analysis, or writing of the manuscript. The remaining authors have disclosed that they do not have any conflicts of interest.